Diego Braguglia
Präsident bei Edimer Pharmaceuticals, Inc.
Ursprung des Netzwerks ersten Grades von Diego Braguglia
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
VI Partners AG
 VI Partners AG Investment ManagersFinance VI Partners AG (VI Partners) is an independent venture capital firm founded in 2001. The firm is headquartered in Schwyz, Switzerland.
11
| Private Company | Investment Managers | 11 |
Xeltis AG
 Xeltis AG Medical SpecialtiesHealth Technology Xeltis AG develops medical devices to transform standards of care in heart valve replacement and vascular surgery. It develops fully bio absorbable synthetic heart valves and vascular grafts intended to enable for the first time the spontaneous growth of natural, healthy valves and vessels. Its medical device platform comprises bioabsorbable heart valves and blood vessels, designed to enable Endogenous Tissue Restoration (ETR), the natural restoration of the complex body part they replace upon implantation. The company was founded by Martijn Cox, Laurent Grandidier and Simon P. Hoerstrup in 2006 and is headquartered in Zurich, Switzerland.
11
| Holding Company | Medical Specialties | 11 |
AB2 Bio SA
 AB2 Bio SA Pharmaceuticals: MajorHealth Technology AB2 Bio SA develops and manufactures drugs. The firm's products include Interleukin-18 Binding Protein and Proprietary Assay. The company was founded in 2010 and is headquartered in Lausanne, Switzerland.
7
| Private Company | Pharmaceuticals: Major | 7 |
iOnctura SA
 iOnctura SA Miscellaneous Commercial ServicesCommercial Services iOnctura SA is a pre-clinical stage biopharmaceutical company focused on the research and development of novel immuno-oncology therapeutics for patients fighting cancer. The company was founded in June 2017 and is headquartered in Geneve, Switzerland.
7
| Holding Company | Miscellaneous Commercial Services | 7 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Diego Braguglia
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| BOSTON SCIENTIFIC CORPORATION | Medical Specialties | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| NESTLÉ S.A. | Food: Major Diversified | Corporate Officer/Principal | |
| 2INVEST AG | Financial Conglomerates | Director/Board Member | |
| AC IMMUNE SA | Pharmaceuticals: Major | Founder | |
| SYMRISE AG | Chemicals: Specialty | Director/Board Member | |
IsoTis NV
 IsoTis NV BiotechnologyHealth Technology IsoTis NV manufactures, markets and sells a range of bone graft substitutes and other related medical devices. These devices are used to enhance the repair and regeneration of bone in spinal and trauma surgery, joint replacements and dental applications. IsoTis' products are primarily used spinal fusion, trauma, joint revision, bone void filling and iliac crest backfills procedures. The company is headquartered in Bilthoven, the Netherlands | Biotechnology | Founder General Counsel | |
LSP Management Group BV
 LSP Management Group BV Investment ManagersFinance LSP Management Group BV (LSP) is an independent European venture capital firm which was founded by Martijn Kleijwegt, Frits van der Have and Tom Schwarz in 1998. Headquartered in Amsterdam, the firm provides financing to early- to mid-stage life science companies. | Investment Managers | Private Equity Investor | |
Nestlé USA, Inc.
 Nestlé USA, Inc. Agricultural Commodities/MillingProcess Industries Nestle USA, Inc. produces dairy and bakery products. Its products include chocolate and confectionaries, beverages, ice cream, juices, milk products, pet food, prepared foods, and sports nutrition. The company is headquartered in Arlington, VA. | Agricultural Commodities/Milling | Corporate Officer/Principal | |
| University of London | College/University | Doctorate Degree | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin Graduate Degree | |
| University of Twente | College/University | Corporate Officer/Principal | |
| University of St. Gallen | College/University | Masters Business Admin Director/Board Member | |
| University College London | College/University | Undergraduate Degree | |
| University of Leiden | College/University | Undergraduate Degree Graduate Degree | |
| University of Zurich | College/University | Corporate Officer/Principal Director/Board Member Doctorate Degree | |
| Swiss Federal Institute of Technology | College/University | Doctorate Degree Doctorate Degree | |
| University of Lausanne | College/University | Undergraduate Degree Corporate Officer/Principal | |
| Ludwig-Maximilians-Universität München | College/University | Corporate Officer/Principal Masters Business Admin | |
| Wuerzburg Schweinfurt University of Applied Sciences | College/University | Doctorate Degree | |
Aescap Venture Management BV
 Aescap Venture Management BV Investment ManagersFinance Aescap Venture Management BV is an independent venture capital investment firm based in Amsterdam. Aescap was founded in 2005 by Michiel de Haan and Dinko Valerio. Inspired by the name of the Greek god of healthcare, Aesculapiu, the firm's name is an acronym for 'Accelerating European Science Companies and Products.' The firm focuses on developing growth in European firms in the biomedical sector. | Investment Managers | Private Equity Investor | |
BioMedPartners AG
 BioMedPartners AG Investment ManagersFinance BioMedPartners AG (BMP), is an independant venture capital firm headquartered in Basel, Switzerland. BMP originated in 2002 as Seed Capital Advisors AG. The firm manages sector-focused venture capital funds including BioMedInvest, BioMedInvest II and BioMedCredit. They specialize in the biomedical sector. | Investment Managers | Chairman | |
| ORPHAZYME A/S | Pharmaceuticals: Major | Director/Board Member | |
| Mckinsey & Co., Inc. (Switzerland) | Corporate Officer/Principal Corporate Officer/Principal | ||
Comme Le Temps SA
 Comme Le Temps SA Other Consumer SpecialtiesConsumer Durables Comme Le Temps SA develops an electronic tactile module for luxury watches. Its invention relates to a wristwatch comprising a digital matrix display with a two-dimensional sheet of touch-sensitive glass, provided with a plurality of electrodes for detecting the movements of at least one finger in two different directions, a processing circuit arranged so as to interpret the signals from said electrodes and to scroll cards on said display in order to permanently replace the initially displayed card with another card. The company is headquartered in St-Prex, Switzerland | Other Consumer Specialties | Founder | |
| The European Society for Biomaterials | Treasurer | ||
Asceneuron SA
 Asceneuron SA Pharmaceuticals: MajorHealth Technology Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
SynAffix BV
 SynAffix BV BiotechnologyHealth Technology SynAffix BV develops next-generation antibody-drug conjugates for targeted cancer and other diseases. The application of the firm?s proprietary GlycoConnect technology, comprising precision modification of a protein's native glycosylation site, allows the fast and simple construction of antibody-drug conjugates that are both stable and homogeneous. The company was founded by Floris van Delft and Sander van Berkel in 2010 and is headquartered in Oss, the Netherlands. | Biotechnology | Director/Board Member | |
Forendo Pharma Oy
 Forendo Pharma Oy Pharmaceuticals: MajorHealth Technology Forendo Pharma Oy provides novel pharmaceutical treatments for endometriosis and low testosterone levels. Its product fispemifene is the first selective estrogen receptor modulator designed only for men, which helps for the treatment of symptoms of low testosterone, in phase II clinical studies in men with secondary hypogonadism; fispemifene has normalized the low testosterone levels. Its 17HSD1-inhibitor focuses on endometriosis, is a potent and selective lead compounds demonstrated in vivo proof of efficacy in disease model of endometriosis. The company was founded by Risto Arvo Sakari Lammintausta in 2013 and is headquartered in Turku, Finland. | Pharmaceuticals: Major | Director/Board Member | |
| PROGYNY, INC. | Miscellaneous Commercial Services | Director/Board Member | |
| KUROS BIOSCIENCES AG | Biotechnology | Director/Board Member Chairman | |
Onward Medical SA
 Onward Medical SA BiotechnologyHealth Technology ONWARD Inc develops medical devices. It also provides stimulation system to rehabilitate individuals with spinal cord injury. The company was founded by Jocelyn Bloch, Sjaak Deckers, Grégoire Courtine, and Vincent Delattre in December 2014 and is headquartered in Lausanne, Switzerland. | Biotechnology | Director/Board Member Director/Board Member | |
Merck Ventures BV
 Merck Ventures BV Investment ManagersFinance Merck Ventures BV (Merck Ventures) is a venture capital arm of Merck KGaA founded in 2009. The firm is headquartered in Amsterdam, the Netherlands. | Investment Managers | Private Equity Investor Private Equity Investor | |
STORM Therapeutics Ltd.
 STORM Therapeutics Ltd. BiotechnologyHealth Technology Storm Therapeutics Ltd. develops small molecule drugs that target RNA-modifying enzymes. It offers research and development of drug molecules for the treatment of specific cancers. The company was founded by Anthony Kouzarides and Eric Miska on April 21, 2015 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
Artios Pharma Ltd.
 Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Macrophage Pharma Ltd.
 Macrophage Pharma Ltd. BiotechnologyHealth Technology Macrophage Pharma Ltd. engages in research and experimental development on biotechnology. The company is headquartered in Berkhamsted, the United Kingdom. | Biotechnology | Director/Board Member | |
Finity SA
 Finity SA Advertising/Marketing ServicesCommercial Services Finity SA provides information services marketing activities. The company is headquartered in Lausanne, Switzerland. | Advertising/Marketing Services | Director/Board Member | |
| The Institute For Technology-Inspired Regenerative Medicine | College/University | Corporate Officer/Principal | |
Ribometrix, Inc.
 Ribometrix, Inc. Pharmaceuticals: MajorHealth Technology Ribometrix, Inc. develops small molecule drugs that target functional RNA structures to create new avenues to treat human disease. The company was founded by Kevin Weeks and Katie Warner and is headquartered in Greenville, NC. | Pharmaceuticals: Major | Director/Board Member | |
| ONWARD MEDICAL N.V. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Swiss Risk & Care
 Swiss Risk & Care Insurance Brokers/ServicesFinance Swiss Risk & Care is a company that provides insurance and pension brokerage services. The private company is based in Vésenaz, Switzerland and has subsidiaries in Switzerland. The CEOs of the company are David Cochet and Pierre Donnersberg. | Insurance Brokers/Services | Director/Board Member | |
EQT Life Sciences Group BV
 EQT Life Sciences Group BV Investment ManagersFinance EQT Life Sciences Group BV (EQT Life Sciences) is a venture capital firm, a subsidiary of EQT AB founded in 2022 after the acquisition of LSP by EQT. The firm is headquartered in Amsterdam, the Netherlands. | Investment Managers | Consultant / Advisor | |
Outrun Therapeutics Ltd.
 Outrun Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Outrun Therapeutics Ltd. is a British biotechnology company founded in 2019 that develops a platform for drug discovery. | Miscellaneous Commercial Services | Director/Board Member | |
Vaximm AG
 Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
Slyde Holding SA
 Slyde Holding SA MiscellaneousMiscellaneous Slyde Holding SA engages in the management and financing of companies in the fields of watchmaking and microelectronics. The company was founded by Alain Nicod on May 10, 2011 and is headquartered in Luins, Switzerland. | Miscellaneous | Founder |
Statistik
International
| Schweiz | 18 |
| Niederlande | 13 |
| Vereinigtes Königreich | 9 |
| Vereinigte Staaten | 7 |
| Deutschland | 5 |
Sektoral
| Health Technology | 18 |
| Consumer Services | 13 |
| Finance | 9 |
| Commercial Services | 7 |
| Process Industries | 3 |
Operativ
| Director/Board Member | 177 |
| Corporate Officer/Principal | 55 |
| Chairman | 49 |
| Private Equity Investor | 18 |
| Independent Dir/Board Member | 18 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Christian C. Wenger | 49 |
| Roel Bulthuis | 29 |
| Thomas D. Szucs | 23 |
| Monika Krüsi Schädle | 21 |
| Hakan Goker | 18 |
| Alain Nicod | 17 |
| Arnd Kaltofen-Ehmann | 16 |
| Fredericus Colen | 15 |
| Joanna Horobin | 15 |
| Gerald D. Cagle | 15 |
| Michel Darnaud | 14 |
| Clemens A. van Blitterswijk | 12 |
| George Fazio | 11 |
| Andrea Pfeifer | 11 |
| Vanessa Malier | 10 |
- Börse
- Insiders
- Diego Braguglia
- Unternehmensverbindungen
